Associations between circulating resistin concentrations and left ventricular mass are not accounted for by effects

Glenda Norman1, Gavin R Norton2, Vernice Peterson1

  • 1Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand Medical School, 7 York Road, Parktown, Johannesburg, 2193, South Africa.

Insights

Resistin, an adipokine, impacts left ventricular mass (LVM) and may contribute to heart failure. This study found resistin

Area of Science:

  • Cardiovascular Endocrinology
  • Renal Physiology
  • Cardiac Remodeling

Background:

  • Resistin, an adipokine, is implicated in heart failure, potentially via effects on left ventricular mass (LVM).
  • The role of resistin's impact on aortic stiffness and renal function in this association remains unclear.

Purpose of the Study:

  • To investigate the relationship between circulating resistin concentrations and LVM.
  • To determine if aortic stiffness (pulse wave velocity, PWV) or renal function (estimated glomerular filtration rate, eGFR) mediate the effects of resistin on LVM.

Main Methods:

  • Cross-sectional study of 647 community participants.
  • Echocardiography measured LVM index (LVMI) and inappropriate LVM (LVMinappr).
  • Assessed relationships between resistin, LVMI, LVMinappr, LVH, PWV, and eGFR using regression analysis.

Main Results:

  • Resistin concentrations were independently associated with LVMI, LVMinappr, LVH, PWV, and eGFR.
  • LVMI, LVMinappr, and LVH were independently associated with PWV and eGFR.
  • Adjustments for PWV or eGFR did not alter the association between resistin and LVM measures.

Conclusions:

  • The association between resistin and LVM is not explained by ventricular-vascular coupling or renal dysfunction.
  • Resistin likely exerts direct effects on the myocardium contributing to LVM.
Abstract

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
385
Vascular Resistance01:20

Vascular Resistance

Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
9.6K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
800
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
476